Newsfeeds - Spark Newswire

2 minute read

Earnings

Looking Into Colfax’s Return On Capital Employed

Today, 4:58 PM

According to Benzinga Pro, during Q2, Colfax (NYSE:CFX) earned $75.94 million, a 23.87% increase from the preceding quarter. Colfax also posted a total of $985.93 million in sales, a 12.14% increase since Q1.

CFX

10 minute read

Earnings Scheduled For October 26, 2021

By Benzinga Insights

Today, 4:58 PM

Companies Reporting Before The Bell • Veoneer (NYSE:VNE) is likely to report quarterly loss at $0.83 per share on revenue of $408.69 million.

AAN

12 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For October 20, 2021

By Benzinga Insights

Today, 4:58 PM

Upgrades

AGL

1 minute read

Morgan Stanley Maintains Equal-Weight on Colfax, Lowers Price Target to $50

By Benzinga Newsdesk

Today, 4:58 PM

Morgan Stanley analyst Joshua Pokrzywinski maintains Colfax (NYSE:CFX) with a Equal-Weight and lowers the price target from $51 to $50.

CFX

1 minute read

Barclays Maintains Underweight on Colfax, Lowers Price Target to $43

By vishwanath@benzinga.com

Today, 4:58 PM

Barclays analyst Julian Mitchell maintains Colfax (NYSE:CFX) with a Underweight and lowers the price target from $44 to $43.

CFX

8 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 10, 2021

By Benzinga Insights

Today, 4:58 PM

ACHC

1 minute read

Goldman Sachs Downgrades Colfax to Neutral, Lowers Price Target to $51

By Benzinga Newsdesk

Today, 4:58 PM

Goldman Sachs analyst Joe Ritchie downgrades Colfax (NYSE:CFX) from Buy to Neutral and lowers the price target from $53 to $51.

CFX

3 minute read

Options

8 Industrials Stocks With Unusual Options Alerts In Today’s Session

By Benzinga Insights

Today, 4:58 PM

This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Unusual trading activity could push option prices to hyperbolic or underperforming levels.

AAL